Herma H. Fidder

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease

Fabian Schnitzler, Herma H. Fidder, Marc Ferrante et al. · Inflammatory Bowel Diseases · 2009 · 672 citations · Full text

Life Sciences, Immunology, Gastroenterology +14

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

Marjolijn Duijvestein, Anne Christine W. Vos, Helene Roelofs et al. · Gut · 2010 · 623 citations

Medicine, Immunology, Surgery +17

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

Fabian Schnitzler, Herma H. Fidder, Marc Ferrante et al. · Gut · 2008 · 533 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

Mirthe E. van der Valk, Marie‐Josée J. Mangen, Max Leenders et al. · Gut · 2012 · 498 citations · Full text

Pharmacy, Pharmacoeconomics, Surgery +17

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

Herma H. Fidder, Fabian Schnitzler, Marc Ferrante et al. · Gut · 2008 · 448 citations

Veterinary Medicine, Immunology, Pharmacotherapy +11